ColumbiaMagazine.com
Printed from:

Welcome to Columbia Magazine  
 
























 
AGs' settlement with drug firm aids KY General Fund

KY General Fund to Receive $500,000 as result of settlement with Johnson & Johnson subsidiary Company's manufacturing division unlawfully promoted such drugs as Rolaids, Tylenol, Zyrtec, brings total going to General Fund to $6.5 million.

By Terry Sebastian or Crystal Staley

FRANKFORT, KY. (May 24, 2017) - Attorney General Andy Beshear today announced that his office will provide more than $574,000 to the state's General Fund after settling with a Johnson & Johnson subsidiary over allegations it unlawfully promoted its over-the-counter drugs from 2009-2011 as complying with manufacturing safety standards.


The drugs include Tylenol, Motrin, Benadryl, St. Joseph Aspirin, Sudafed, Pepcid, Mylanta, Rolaids, Zyrtec and Zyrtec Eye Drops - all manufactured and distributed by McNeil Consumer Healthcare Division, which is now a division of Johnson & Johnson Consumer Inc., a wholly owned subsidiary of Johnson & Johnson.

The multimillion-dollar settlement reached by a group of state attorneys general and Johnson & Johnson, and submitted to Franklin Circuit Court today, resolves allegations that McNeil promoted these drugs as complying with federally mandated manufacturing standards even though the U.S. Food and Drug Administration found that some of its manufacturing facilities were not in compliance with federal standards between 2009 and 2011.

"Through this settlement we are once again holding a drug company accountable for not only violating Kentucky's consumer protection laws but for placing our families and children at risk by not following federal manufacturing safety standards," Beshear said. "The judgment we are announcing today is an important step toward ensuring the safe manufacture and lawful marketing and promotion of over-the-counter drugs to all Kentuckians."

The company's alleged quality control lapses resulted in recalls of many of its drugs manufactured between 2009 to 2011 including several used for pediatric or infant use. Failure of a company to comply with FDA standards may result in bacterial or foreign body contamination of a drug, or super-potent or ineffective medicines.

Beshear said Kentucky served on the executive committee on the multistate lawsuit that involved 42 states and the District of Columbia. Neighboring states joining in the settlement include Illinois, Indiana, Ohio, Tennessee, Virginia, and West Virginia.

Recent settlements by Beshear's office with Mortgage Electronic Registration Systems Inc. (MERS), Volkswagen, Hyundai-Kia, Bristol-Myers Squibb and Western Union have provided more than $6.5 million to the state's General Fund.


This story was posted on 2017-05-25 06:18:42
Printable: this page is now automatically formatted for printing.
Have comments or corrections for this story? Use our contact form and let us know.


 

To sponsor news and features on ColumbiaMagazine, please use our contact form.

 

























 
 
Quick Links to Popular Features


 

ColumbiaMagazine.com content is available as an RSS/XML feed for your RSS reader or other news aggregator.
Use the following link: http://www.columbiamagazine.com/columbiamagazinerss.php.

Contact us: Columbia Magazine and columbiamagazine.com are published by D'Zine, Ltd., PO Box 906, Columbia, KY 42728.
Phone: 270-250-2730 Fax: 270-751-0401


Please use our contact page, or send questions about technical issues with this site to webmaster@columbiamagazine.com. All logos and trademarks used on this site are property of their respective owners. All comments remain the property and responsibility of their posters, all articles and photos remain the property of their creators, and all the rest is copyright 1995-Present by Columbia! Magazine and D'Zine, Ltd. Privacy policy: use of this site requires no sharing of information. Voluntarily shared information may be published and made available to the public on this site and/or stored electronically. Anonymous submissions will be subject to additional verification. Cookies are not required to use our site. However, if you have cookies enabled in your web browser, some of our advertisers may use cookies for interest-based advertising across multiple domains. For more information about third-party advertising, visit the NAI web privacy site.